BARCELONA, Feb 26 (Reuters) - Spanish drugmaker Grifols GRLS.MC reported on Thursday a net profit of 402 million euros ($473.96 million) for 2025, more than double what it recorded the previous year, driven by revenues of 7.5 billion euros, up 7% from a year earlier.
Analysts polled by LSEG expected a profit of 427 million euros and revenues of 7.5 billion euros during the period.
Adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) rose to 1.8 billion euros, in line with expectations.
The company has lost around 25% of its market value since January 2024, when Gotham City Research, a short-seller fund, released multiple reports accusing Grifols of overstating earnings and understating debt, which Grifols denies. It has sued the fund.
($1 = 0.8482 euros)
(Reporting by Joan Faus; editing by Charlie Devereux)
((joan.faus@thomsonreuters.com;))